We have shown previously that angioten~in-ll (A-II) controls proto-oncogene (c.Jbs, juJ~-B and e-ju,) mRNA accumulation in bovine adrenal fa.~eieulata cells (BAC). Since BAC contain both subtypes tAT-1 and AT-2)of the A-Ii receptor, we have investigated which sublype was involved in the effect of A-II on proto.oncogene mRNA by using a selective antagonist for AT-I (DUP 753) and for AT-2 (CGP 42112A), DUI a 753, bat n~ CGP 42112A, inhibited the stimulatory efi'ect of A-il on proto.oncogene mRNA, with IDeas of 4 × 10 -~ M, 7 × 10 -* M and 2 × 10 -~ M for c-Jbs, jtm.B and e-jttn, respectively. Neither of the two antagonists by themselve~ had a direct effect on proto-oncogene mRNA. As the A-ll AT-I receptors are coupled to the phospholipase C system in BAC, we haw investigated whether the A-ll effects on the proto-oncogenes were mediated ~y protein kina,~e C (PKC) or by Ca ~-" calmodulin. First, activation of PKC by the phorbol ester, PMA, increased the level of the three proto~nco-gene mRNAs, whereas calcium ionophore had no effect. Second, staurosparine, a specific inhibitor of PKC, redtzeed the ztimulatory action of A-I! on proto.oneogene mR NA by 80-.90%, whereas trilluoroperazine, an inhibitor of ealmadulin, had no significant effect. These results demonstrate that the effects of A-I! on proto-oneo~ene mRNA are mediated by ATI receptor subtylx:S, mainly through activation of the PKC pathway.